Table 1. Patient Characteristics and CRP Concentration.
| Characteristic | Men | Women | ||||
|---|---|---|---|---|---|---|
| With severe COVID-19 (n = 66) | Without severe COVID-19 (n = 24) | P value | With severe COVID-19 (n = 37) | Without severe COVID-19 (n = 25) | P value | |
| Age, mean (SD), y | 68 (11) | 55 (15) | <.001 | 68 (14) | 51 (19) | <.001 |
| BMI, mean (SD) | 26.7 (6.0) | 30.0 (8.0) | .04 | 32.6 (9.3) | 34.3 (8.1) | .45 |
| CCI score, median (IQR) | 3 (2-4) | 2 (0-3) | .02 | 2 (2-4) | 1 (0-2) | <.001 |
| Ever smoked, No. (%) | 35 (53.0) | 12 (50.0) | .46 | 18 (48.6) | 9 (36.0) | .32 |
| Race, No. (%) | ||||||
| White | 20 (30.3) | 5 (20.8) | .72 | 5 (13.5) | 2 (8.0) | .54 |
| African American | 44 (66.7) | 19 (79.2) | 32 (86.5) | 22 (88.0) | ||
| Asian | 1 (1.5) | 0 | 0 | 0 | ||
| Othera | 1 (1.5) | 0 | 0 | 1 (4.0) | ||
| Duration of hospital stay, median (IQR), d | 14 (5-23) | 5 (3-10) | .002 | 10 (6-22) | 5 (2-7) | <.001 |
| CRP, median (IQR), mg/dL | 14.6 (6.0-21.9) | 7.2 (3.1-10.8) | .08 | 10.8 (5.1-18.9) | 7.9 (1.4-13.9) | .13 |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CCI, Charlson Comorbidity Index; CRP, C-reactive protein; IQR, interquartile range.
SI conversion factor: To convert CRP to mg/L, multiply by 10.
a
Other category includes Native Hawaiian and Pacific Islander individuals and American Indian and Alaskan native individuals.